A comparative population pharmacokinetic analysis for methylprednisolone following multiple dosing of two prodrugs in patients with acute asthma

British Journal of Clinical Pharmacology

Volumn 43, Issue 6, 1997, Pages 589-592

  Parker, T J ^a,b   Daley Yates, P T ^a   Wood, S A ^a  

^a PFIZER INC   (United States)

^b Servier R and D Ltd   (United Kingdom)

Author keywords

Bioavailability; Methylprednisolone; Methylprednisolone suctinate; Methylprednisolone suleptanate; Population pharmacokinetics

Indexed keywords

METHYLPREDNISOLONE; METHYLPREDNISOLONE SODIUM SUCCINATE; METHYLPREDNISOLONE SULEPTANATE; UNCLASSIFIED DRUG;

ADULT; AREA UNDER THE CURVE; ARTICLE; ASTHMA; BAYES THEOREM; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DOUBLE BLIND PROCEDURE; DRUG BIOAVAILABILITY; DRUG DISPOSITION; DRUG HALF LIFE; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; STEADY STATE;

EID: 0030738374     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.1997.00599.x     Document Type: Article

References (7)

1. Ozawa N, Yaniazaki S, Chiba K, et al. Studies of the pharmacokinetics of methylprednisolone suleptanate (U-67590A) 1, Blood level profile distribution, excretion and reabsorption of tritiated or carbon-14 U-67590A in rats after a single intravenous dose. Pharmacometrics 1993; 45: 487-505.
2. Ozawa N, Yaniazaki S, Chiba K, et al. Studies of the pharmacokinetics of methylprednisolone suleptanate (U-67590A) 3, Plasma concentration and excretion of tritiated or carbon-14 U-67590A in dogs after a single intravenous dose. Pharmacometrics 1993; 45; 519-528.
3. Weber DJ, Vanderlugt JT, Olanoff LS, Shah JA. Comparative pharmacokinetics of methylprednisolone and its prodrugs following intravenous doses of methylprednisolone sodium succinate Solu-Medrol and methylprednisolone suleptanate Promedrol in humans. Clin Pharmacol Ther 1988; 43: 189.
4. Vanderlugt JT, Weber DJ, Metzler CM, Olanoff LS. Comparisons of single and multiple dose pharmacokinetics of methylprednisolone sodium succinate and methylprednisolone suleptanate. Clin Pharmacol Ther 1989; 45: 148.
5. NONMEM Users Guide, NONMEM project group, University of California, San Francisco.
6. Siphar/Dos Version 4.0b, Simed, CRÉTEIL, Cedex-France.
7. SAS/WIN Version 6.08, SAS Institute Inc., SAS Circle, Box 6000, Cary, NC 27512-8000, USA.